SpectraWAVE has named Eman Namati, PhD, as CEO to lead the development and launch of the firm's photonic imaging system for coronary artery disease.
The system is designed to identify plaques and patients at risk of further complications due to coronary artery disease.
Namati has more than a decade of experience in the medical imaging field, including as president and CEO of optical coherence tomography technology developer NinePoint Medical.
